Olema Pharmaceuticals, Inc. (OLMA)
$7.82+0.00%Close
SELLCRISIS · day 21
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $683M
- Beta
- 1.99
- P/E (TTM)
- -3.74
- Short % float
- 20.75%
- Days to cover
- 10.2
- SI change
- -8.5%
- 1W
- -4.98%
- 1M
- -26.85%
- vs SPY 1W
- -6.14%
- vs SPY 1M
- -29.84%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on OLMA?
- LOPJLB’s latest quantitative signal on Olema Pharmaceuticals, Inc. (OLMA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is OLMA in?
- Olema Pharmaceuticals, Inc. (OLMA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Olema Pharmaceuticals, Inc. (OLMA) do?
- Olema Pharmaceuticals, Inc., a biopharmaceutical enterprise in the clinical development stage, is dedicated to discovering, advancing, and commercializing therapeutic solutions for women's oncology. Headquartered in San Francisco, California, the company was established in 2006 and rebranded from CombiThera, Inc. in March 2009. Its most promising investigational compound, OP-1250, an estrogen r…